The study aimed to quantify the relationship between insulin antibodies (IAs) and the 2-hour insulin to C-peptide molar ratio (2h-ICPR) in type 2 diabetes mellitus (T2DM) patients using a multiple linear regression model. The sample consisted of 274 T2DM patients from Xiang’an Hospital of Xiamen University, with data collected from April 2019 to December 2022. The multiple linear regression analysis revealed statistically significant relationships between IAs and the independent variables age (p = 0.004) and 2h-ICPR (p ≤ 0.001), suggesting that these variables are unlikely to be associated with IAs by chance. Clinically, the finding that 2h-ICPR can serve as a preliminary screening indicator for insulin antibody testing is significant, as it offers a potential tool for early detection and management of insulin antibodies in T2DM patients, which could improve treatment outcomes.
However, the generalizability of the study’s findings may be limited by several factors. Firstly, the sample characteristics, including the specific demographics of the patients from a single hospital, may not represent the broader T2DM population, potentially affecting the applicability of the results to other settings. Secondly, the study design and setting, being confined to a specific hospital and healthcare system, may limit the findings’ relevance to different clinical practices and patient populations. Lastly, the generalizability would be enhanced by replication of the study in diverse settings and populations, ensuring consistency and reliability of the results across various contexts. The current findings are promising, but further studies are needed to confirm their broader applicability.